Asia sales slide at Mead Johnson but CEO insists China business ‘remains on track’
Infant nutrition firm Mead Johnson, which is in the process of being taken over by Reckitt Benckiser, saw sales in its core Asia markets tumble in the first quarter.
Archives for April 30, 2017
Vitamin K2 MK-7: A stability challenge, a market study
Paid for by Kappa Bioscience
Demand for vitamin K2 has increased rapidly over the past decade as awareness of its role in bone and cardiovascular health has spread. However, studies run by Kappa Bioscience show many K2 products contain lower-than-claimed levels of the vitamin, a...
Paper #2: Inflammatory Conditions
Paid for by International Probiotics Association
Individual microbiomes may influence tendencies to autoimmune diseases and inflammatory conditions including arthritis and fibromyalgia.
Clinical data supports safety, bioavailability, and biological activity of pomegranate metabolite
Development of products with urolithin A, a metabolite from pomegranate compounds, took a big step forward as scientists reported results from a Phase 1 trial supporting the safety, bioavailability, and biological activity of the compound.
Pharmachem fetches $660 million in sale to major chemical firm
Privately held Pharmachem Laboratories has been sold to Ashland, a diversified chemical company, for a reported purchase price of $660 million.
Developer debuts patented ingredient line with blend based on ‘ideal ratio’ of amino acids
An amino acid ingredient first developed to help burn victims battle muscle wasting is now debuting on the dietary supplement market.
Food Vision Asia 2017
FSSAI admits high-handed past, now seeks more industry collaboration
According to a senior official at the FSSAI, the food authority has now cast off its reputation as an impregnable fortress whose top-down approach risked alienating food players across India.
Quantum Health: 'We feel like we could grow our business with no marketing, just off the quality of our products'
With consumers increasingly seeking out natural solutions to immune health, Quantum Health’s focus on quality is helping to drive double digit growth across its portfolio.